New-onset autoimmune phenomena post-COVID-19 vaccination

Area of Science:

• Immunology
• Vaccinology
• Public Health

Background:

• The COVID-19 pandemic caused by SARS-CoV-2 has had severe global health and economic impacts.
• Vaccination is a key strategy to mitigate COVID-19 severity and mortality.
• Concerns exist regarding the long-term safety and efficacy data for some rapidly approved COVID-19 vaccines.

Purpose of the Study:

• To review and summarize emerging evidence on autoimmune manifestations post-COVID-19 vaccination.
• To explore potential mechanisms contributing to vaccine-associated autoimmunity, such as molecular mimicry.
• To provide an overview of current understanding regarding the association between COVID-19 vaccines and autoimmune diseases.

Main Methods:

• Literature review of reported autoimmune phenomena following COVID-19 vaccination.
• Analysis of potential immunological mechanisms involved in vaccine-induced autoimmunity.
• Synthesis of current scientific understanding and controversial aspects of the topic.

Main Results:

• An increasing number of new-onset autoimmune conditions have been reported after COVID-19 vaccination.
• Examples include immune thrombotic thrombocytopenia, autoimmune liver diseases, Guillain-Barré syndrome, IgA nephropathy, rheumatoid arthritis, and systemic lupus erythematosus.
• Mechanisms like molecular mimicry and vaccine adjuvants are implicated in the development of these autoimmune responses.

Conclusions:

• The relationship between COVID-19 vaccines and autoimmune manifestations requires further investigation to establish causality.
• Despite ongoing research into potential risks, the benefits of mass COVID-19 vaccination in preventing severe disease and death remain substantial.
• This summary aims to aid clinical assessment and management of patients experiencing autoimmune issues after vaccination.